Clinical Trial Update: Prevention of Maternal-fetal Cytomegalovirus Transmission After Primary Maternal Infection, GW ≤ 14 (PreCyssion) [Phase 3]

View source ↗

Summary

A Phase 3 trial (PreCyssion) evaluating prevention of maternal-fetal cytomegalovirus transmission after primary maternal infection in early pregnancy (gestation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Cytomegalovirus Infection

Snippet

Sponsor: Biotest | Conditions: Congenital Cytomegalovirus Infection | Phase 3 | Status: TERMINATED